Novartis Scraps Non-Compete Payment to Departing Chairman
Wednesday, February 20, 2013 - 02:40
in Mathematics & Economics
The Swiss drug company faced criticism from shareholders and lawmakers for agreeing to pay Daniel Vasella $78 million over six years.